← Leaderboards
David Huw Davies
Immport Therapeutics, Inc.
$5,346,195
Attributed
$5,346,195
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2008–24$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$5,346,195 · 2
By mechanism
R44$2,991,855 · 1
U01$2,354,340 · 1
Top collaborators
No co-investigators on record.
Most similar at Immport Therapeutics, Inc.
Same institution · by research overlap
- Xiaowu Liang$1,118,920
Others in their field
Top investigators on “Antigens”
- Barton F Haynes · Duke University$488,918,563
- Lawrence Corey · Fred Hutchinson Cancer Center$325,880,100
- Dennis R. Burton · Scripps Research Institute$291,395,948
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$245,204,950
- Jeffrey P Krischer · University Of South Florida$208,289,343
- Dan H. Barouch · Fred Hutchinson Cancer Center$124,506,327
Research focus
AntigensInfectionMonitorVaccine AntigenMicrobialAlgorithmsProtein MicrochipsPathogenResponseVirusAntibodiesGenesBaseAgonistAvidity2019-NcovAdaptive Immune SystemCell MotilityCellsAntibody Titer MeasurementBehavioralAdjuvantAntigen-Presenting CellsB Cell Repertoire
Grant awards (7)
Defining molecular mechanisms of combination adjuvants: a systems immunology, transcriptomics and imaging approach$576,184
U01 · FY2024 · AI · contact PI
Defining molecular mechanisms of combination adjuvants: a systems immunology, transcriptomics and imaging approach$592,289
U01 · FY2023 · AI · contact PI
Defining molecular mechanisms of combination adjuvants: a systems immunology, transcriptomics and imaging approach$575,733
U01 · FY2022 · AI · contact PI
Defining molecular mechanisms of combination adjuvants: a systems immunology, transcriptomics and imaging approach$610,134
U01 · FY2021 · AI · contact PI
Seriodiagnostic arrays for biodefense and emerging infectious diseases$991,855
R44 · FY2010 · AI · contact PI
Seriodiagnostic arrays for biodefense and emerging infectious diseases$1,000,000
R44 · FY2009 · AI · contact PI
Seriodiagnostic arrays for biodefense and emerging infectious diseases$1,000,000
R44 · FY2008 · AI · contact PI